Delaware Administrative Code
Title 1 - Authorities, Boards and Commissions
100 - Delaware Health Information Network
102 - Delaware Health Information Network Regulations on Use of Clinical Data for Approved Analytic Purposes
Section 102-4.0 - Structure and Duties of the Committee
Current through Register Vol. 28, No. 3, September 1, 2024
4.1 The Committee shall have a chairperson and members appointed by the Board.
4.2 The Committee shall be comprised of five (5) to eleven (11) members and shall be representative of various stakeholder groups, including, where possible, consumers, employers, health plans, hospitals, physicians, ACO Administrators, researchers, and State government.
4.3 The Committee shall finalize a data request application, establish business operating rules for the review and consideration of applications, and determine a schedule for reviewing applications. These business rules shall be subject to periodic updates by the Committee and shall be maintained on the DHIN website.
4.4 The Committee shall consider any comments received from Data Sending Organizations whose Available Clinical Data is being requested. The Committee shall approve an application by majority vote after finding the following:
4.5 The Committee reserves the right to ask an applicant to acquire Institutional Review Board review, or its equivalent, prior to approving an application.
4.6 The Committee may ask for any information or assurances from a requesting party that it determines, in its discretion, may be needed in order to evaluate the application.
4.7 After a decision is reached by the Committee, public notice will be posted on the DHIN website that an application for data access was received, by whom it was submitted and for what purposes, and the decision of the Committee to grant or deny the application. The final determination of the Committee shall not be subject to appeal.